豬苓湯加減治療BPH術(shù)后留置尿管相關(guān)的膀胱過度活動(dòng)癥臨床研究.pdf

1、廣州中醫(yī)藥大學(xué)學(xué)位論文原創(chuàng)性聲明本人鄭重聲明：所呈交的學(xué)位論文，是個(gè)人在導(dǎo)師的指導(dǎo)下，獨(dú)立進(jìn)行研究工作所取得的成果。除文中已經(jīng)特別加以注明引用的內(nèi)容外，本論文不含任何其他個(gè)人或集體已經(jīng)發(fā)表或撰寫過的作品成果。對本文的研究做出重要貢獻(xiàn)的個(gè)人和集體，均已在文中以明確方式標(biāo)明并致謝。本人完全意識(shí)到本聲明的法律結(jié)果由本人承擔(dān)。學(xué)位論文作者簽名塑塑虱乏幺日期：2014年3月25日關(guān)于學(xué)位論文使用授權(quán)的聲明本人完全了解廣州中醫(yī)藥大學(xué)有關(guān)保留使用學(xué)位

2、論文的規(guī)定，同意學(xué)校保留或向國家有關(guān)部門機(jī)構(gòu)送交論文的復(fù)印件和電子版，允許被查閱和借閱。本人授權(quán)廣9、It中醫(yī)藥大學(xué)可以將本學(xué)位論文的全部或部分內(nèi)容編入有關(guān)數(shù)據(jù)庫進(jìn)行檢索，可以采用影印、縮印或其他復(fù)印手段保存和匯編本學(xué)位論文。(保密論文在解密后應(yīng)遵守此規(guī)定)論文作者簽名雌論文導(dǎo)師簽名瞪!費(fèi)日期：加l(p年；月M日ThestudyofaiteringPoIyporusDecoctionoftheimprovementofquaIityof

3、IifeoftheindweIIingcatheterrefatedoveractivebIadderofbenignprostatehypertrophypatientsaftersurgerySpeciaItyoClinicaImediCiBeWithcombinationofTCMandWesternmediCiBeAuthor：WenGuoqiangTutor：Prof0iUYongchaoAbstractObjectiMeTo

4、observetheeffectofthetreatmentbyalteringPolyporusDecoctionofindwellingcatheterrelatedoveractivebladderofbenignprostatehypertrophypatientsaftersurgeryToexplorethecurativeeffectofTCMtoimprovethequalityof1ifeinbenignprostat

5、ehypertrophypatientsaftersurgerywiththeindwellingcatheterrelatedoveractivebladderMethodsAccordingtothestudydesign，selectingcasesmettheinclusioncriteriafortreatmentandobservationAllpatientswerefromthesurgeryloftheFirstAff

6、iliatedHospitalofGuangzhouUniversityofTCM，thetimelimitfromJune2013toFebruary2014，atotalof31caseswereselected31casesweredividedto3groupsbytherandomnumbertableThetreatmentgroupwas11cases，thecontrolgroupwas9cases，theblankgr

7、ouPwas11casesAgegroup，IPSSscore，QOLscoreandtheweightoftheprostatewerecheckedbythestatisticaltreatment，therewasnosignificantdifference(PO05)Afteroperationinthethreegroupsweregivendrugtreatment①Thepatientsintreatmentgroupw

8、erecuredbyalteringPolyporusDecoction，whichwascuredaftertherecoveryofgastrointestinalfunctionThetreatmentwastwiceadaybyonepotionaday，whichwasendedafterthecatheterremoval②ThepatientsincontrolgroupwerecuredbyTolterodineTart

9、rateSustainedReleaseTablets(4mg／piece)，whichwascuredaftertherecoveryofgastrointestinalfunctionThetreatmentwasonceadaybyonepiece，whichwasendedafterthecatheterremoval③ThepatientsinblankgroupwerenottargetedcuredAftercathete